Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-01-26 @ 2:07 PM
Study NCT ID:
NCT05204368
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-16
First Post:
2022-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)
Sponsor:
Evopoint Biosciences Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Complicated Urinary Tract Infection Including Acute Pyelonephritis | View |
Keywords: